Skip to Main Content

Advertisement

Skip Nav Destination

Clinical Validation of MCL35 in Mantle Cell Lymphoma Patients ≥65 Years Receiving Bendamustine-Rituximab

Blood (2021) 138 (Supplement 1): 3517.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement